About this trial
This multicenter randomized controlled trial evaluates whether a pre-procedural risk score-based endoscopist assignment strategy reduces intraprocedural pain in high-risk patients undergoing unsedated colonoscopy. High-risk patients (risk score \>5) are randomized 1:1 to either the intervention group (examination performed by expert endoscopists with ≥5,000 colonoscopy experiences) or the control group (examination performed by endoscopists assigned per routine hospital scheduling). The primary outcome is the proportion of patients reporting moderate-to-severe pain during colonoscopy, assessed by a blinded research assistant using a 4-point VRS. A total of 106 high-risk patients will be enrolled from two centers in China.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 18-75 years.
Outpatient or inpatient undergoing colonoscopy for medical screening, polyp surveillance, or polypectomy.
Pre-procedural risk score >5 (based on the following scoring system: BMI <19 [5 points], female sex [1 point], history of abdominal or pelvic surgery [2 points], constipation [3 points]).
Disqualifiers
Patients who have received sedation or analgesia prior to colonoscopy.
Patients unwilling to cooperate or unable to provide informed consent.
Incomplete intestinal obstruction.
Inflammatory bowel disease, multiple polyposis syndromes, or severe chronic cardiac or pulmonary disease.
Trial design
Parallel
Treatments tested in this trial
Risk Score-Based Endoscopist Assignment
Other interventionHigh-risk patients (pre-procedural risk score \>5) undergoing unsedated colonoscopy are assigned to expert endoscopists who have completed at least 5,000 colonoscopy procedures.
Treatment groups
Trial outcomes
Primary outcomes
Proportion of Participants with Moderate-to-Severe Pain During Colonoscopy
Pain intensity is assessed using a VRS-4 ( none, mild, moderate, severe) immediately after the colonoscopy by a research assistant who is blinded to group allocation. Moderate or severe pain is defined as the primary outcome event.
Secondary outcomes
Adenoma Detection Rate (ADR)
Proportion of participants with at least one histologically confirmed adenoma detected during colonoscopy. All resected polyps are sent for pathological examination.
Willingness to Undergo Repeat Unsedated Colonoscopy
Proportion of participants who respond "yes" when asked whether they would be willing to undergo a repeat unsedated colonoscopy in the future.
Patient Satisfaction
Patient satisfaction is assessed by a research assistant using a standardized questionnaire, graded as satisfied, fair, or dissatisfied.
Cecal Intubation Time
Time from endoscope insertion to successful cecal intubation, measured in minutes.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: